<DOC>
	<DOCNO>NCT00753597</DOCNO>
	<brief_summary>This pilot study B lymphocyte depletion therapy attempt salvage adrenal steroidogenic capacity ten subject early autoimmune Addison 's disease . During first twelve week treatment , additional glucocorticoid therapy ( prednisolone ) give ensure wellbeing rest steroidogenic apparatus target autoimmune attack . Glucocorticoids gradually withdraw , controlled fashion , adrenal function re-evaluated 13 , 26 , 39 52 week . The primary endpoint restoration steroidogenic function judge conventional endocrine index adrenocortical function . B cell depletion may ameliorate autoimmune attack adrenal cell , potentially allow state immune tolerance restore subsequent recovery adrenal steroidogenic capacity .</brief_summary>
	<brief_title>Rescue Steroidogenic Capacity Adrenocortical Failure Study ( RADS )</brief_title>
	<detailed_description />
	<mesh_term>Rituximab</mesh_term>
	<criteria>Clear evidence primary adrenal failure ( elevated ACTH , pigmentation , electrolyte disturbance ) Basal stimulate cortisol &lt; 400 nmol/l &gt; 100nmol/l Active viral infection , pregnancy breast feeding , previous immunosuppression , diabetes , cardiorespiratory disease , renal failure , hepatic disease , cancer Calcified enlarge adrenal CT scan , active TB</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>B cell depletion</keyword>
	<keyword>steroidogenesis</keyword>
</DOC>